Netherlands· NL-bb04cec38554
Hydrochloorthiazide Mylan 25 mg, tabletten
A hydrochlorothiazide product containing hydrochloorthiazide, registered in Netherlands by Mylan B.V.. The same ATC class is registered in 16 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Hydrochlorothiazide is registered in 16 of 19 countries.
Countries holding a registration under ATC C03AA03 (hydrochlorothiazide), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 9 of them publish a price we can compare per daily dose
Hydrochlorothiazide · ATC C03AA03
16 / 19 countries
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of hydrochlorothiazide costs, country by country.
Normalised to the WHO defined daily dose (25 mg), the median price runs from $0.048 in France to $0.21 in Switzerland — a ×4.4 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Hydrochlorothiazide · price per daily dose (25 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.21
- IT Italy$0.075
- FR France$0.048
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- HYDROCHLOORTHIAZIDE
- Manufacturer
- Mylan B.V.
- Country
- Netherlands (NL)
- ATC code
- C03AA03
- ATC class
- Hydrochlorothiazide
- Defined daily dose
- 25 mg, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id112548
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
490 interactions on record for hydrochlorothiazide.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Hydrochlorothiazide · interactions on record
490 records
- 4 severe
- 208 moderate
- 21 minor
- 169 info
Most severe, free to view
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- Aminolevulinic acidL01XD04severe
- Arsenic trioxideL01XX27severe
88 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under C03AA03
Hydrochlorothiazide, as other registers publish it.
- CanadaAPO-HYDROCHLOROTHIAZIDEAPOTEX INC
- CanadaAPO-HYDROCHLOROTHIAZIDEAPOTEX INC
- CanadaAPO-HYDROCHLOROTHIAZIDEAPOTEX INC
- FinlandDichlotrideMerck Sharp & Dohme B.V.
- SwitzerlandEsidrex
- NorwayEsidrexLaboratoires Juvisé Pharmaceuticals
- ItalyESIDREXLABORATOIRES JUVISE' PHARMACEUTICALS
- FranceESIDREX 25 mg, comprimé sécableLABORATOIRES JUVISE PHARMACEUTICALS
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f58c6509-b691-41f8-9788-d412ad4fc964 GET /v1/drugs/f58c6509-b691-41f8-9788-d412ad4fc964?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h112548_smpc.pdf",
"strength": null,
"atc_label": "Hydrochlorothiazide",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg112548",
"excipients": [
"LACTOSE 1-WATER",
"MAGNESIUMSTEARAAT (E 470b)",
"MAÏSZETMEEL",
"SILICIUMDIOXIDE (E 551)"
],
"substances": [
"HYDROCHLOORTHIAZIDE"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h112548.pdf",
"authorised_at": "2012/12/04",
"procedure_number": "DE/H/1641/002",
"dispensing_status": "Uitsluitend recept",
"registration_number": "112548",
"additional_monitoring": "N"
}See everything about hydrochlorothiazide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.